Active, Not Recruiting
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
NCT03800134
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
- Locations
-
- Research Site Phoenix, Arizona, United States
- Research Site Duarte, California, United States
- Research Site Orange, California, United States
- Research Site Aurora, Colorado, United States